Universidad de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (37)

2004

  1. Techniques: New approaches to the delivery of biopharmaceuticals

    Trends in Pharmacological Sciences, Vol. 25, Núm. 7, pp. 382-387

2003

  1. Drug delivery in biotechnology: Present and future

    Current Opinion in Biotechnology, Vol. 14, Núm. 6, pp. 659-664

1997

  1. Influence of route of administration and dosage form in the pharmacokinetic and bioavailability of salbutamol

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 22, Núm. 2, pp. 145-150

1996

  1. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of four salbutamol sulphate formulations

    International Journal of Pharmaceutics, Vol. 139, Núm. 1-2, pp. 45-52

1995

  1. The Influence of Adrenalin on the Pharmacokinetics of Interpleurally Administered Lidocaine in Patients With Pancreatic Neoplasia

    The Journal of Clinical Pharmacology, Vol. 35, Núm. 4, pp. 426-431

1994

  1. Interspecies Scaling of Cimetidine–Theophylline Pharmacokinetic Interaction: Interspecies Scaling in Pharmacokinetic Interactions

    Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 11, Núm. 7, pp. 945-950

  2. On the employment of λ-carrageenan in a matrix system. II. λ-Carrageenan and hydroxypropylmethylcellulose mixtures

    Journal of Controlled Release, Vol. 30, Núm. 2, pp. 175-182

1993

  1. On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum

    Journal of Controlled Release, Vol. 26, Núm. 2, pp. 119-127

1992

  1. Pharmacokinetic‐pharmacodynamic modeling: Time‐dependent protein binding—an alternative interpretation of clockwise and counterclockwise hysteresis

    Journal of Pharmaceutical Sciences, Vol. 81, Núm. 3, pp. 232-236

  2. Rheological beheviour of hydrophilic polymers and drug release from erodible matrices

    Journal of Controlled Release, Vol. 18, Núm. 3, pp. 205-212

1991

  1. Biotransformation kinetic of binifibrate and identification of its metabolites

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 5, pp. 172-177

  2. Influence of ecxipient in the release of ketamine from suppositories

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 2, pp. 52-54

  3. Pharmacokinetics and distribution of ketamine after extradural administration to dogs

    British Journal of Anaesthesia, Vol. 67, Núm. 3, pp. 310-316

  4. Pharmacokinetics of cefazoline and dibenzylamine administered in a sustained drug delivery system to healthy volunteers

    International Journal of Pharmaceutics, Vol. 67, Núm. 3, pp. 259-264

  5. VALIDEZ DE LA INVESTIGACION PRECLINICA EN EL DESARROLLO DE NUEVOS ANTIBIOTICOS. ASPECTOS FARMACOCINETICOS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 9, Núm. 6, pp. 361-369

1990

  1. Pharmacokinetics of dibenzylamine administered in a sustained drug delivery system with cefazolin

    Biopharmaceutics & Drug Disposition, Vol. 11, Núm. 9, pp. 797-806

1989

  1. Determination of low concentrations of dibenzylamine in human plasma and urine by gas chromatography with a nitrogen-phosphorus detector

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 490, Núm. C, pp. 206-212

  2. Pharmacokinetics of rectal ketamine in children

    British Journal of Anaesthesia, Vol. 63, Núm. 6, pp. 671-674

1988

  1. Allometric study of ketamine pharmacokinetics

    Revista de Farmacologia Clinica y Experimental, Vol. 5, Núm. 3, pp. 331-336

  2. Bioequivalence study of two oral formulations of paracetamol

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 26, Núm. 5, pp. 232-236